Good news for the mdx mouse community: Improved dystrophin restoration after skipping mouse dystrophin exon 23

Good news for the mdx mouse community: Improved dystrophin restoration after skipping mouse dystrophin exon 23

Bibliographic Details
Main Author:	Annemieke Aartsma-Rus
Format:	Article
Language:	English
Published:	Elsevier 2022-12-01
Series:	Molecular Therapy: Nucleic Acids
Online Access:	http://www.sciencedirect.com/science/article/pii/S216225312200275X

Similar Items

Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse.
by: Lu, Q, et al.
Published: (2003)

Use of antisense-mediated exon skipping to generate dystrophin in muscles of the mdx dystrophic mouse
by: Lu, Q, et al.
Published: (2004)

A fusion peptide directs enhanced systemic dystrophin exon skipping and functional restoration in dystrophin-deficient mdx mice.
by: Yin, H, et al.
Published: (2009)

Rescue of a dystrophin-like protein by exon skipping normalizes synaptic plasticity in the hippocampus of the mdx mouse
by: Glenn Dallérac, et al.
Published: (2011-09-01)

In-frame dystrophin following exon 51-skipping improves muscle pathology and function in the exon 52-deficient mdx mouse.
by: Aoki, Y, et al.
Published: (2010)

Hexose enhances oligonucleotide delivery and exon skipping in dystrophin-deficient mdx mice
by: Gang Han, et al.
Published: (2016-03-01)

Adenine base editing-mediated exon skipping restores dystrophin in humanized Duchenne mouse model
by: Jiajia Lin, et al.
Published: (2024-07-01)

Effective exon skipping and dystrophin restoration by 2'-o-methoxyethyl antisense oligonucleotide in dystrophin-deficient mice.
by: Lu Yang, et al.
Published: (2013-01-01)

Nanopolymers improve delivery of exon skipping oligonucleotides and concomitant dystrophin expression in skeletal muscle of <it>mdx </it>mice
by: Sirsi Shashank R, et al.
Published: (2008-04-01)

Exon skipping peptide-pmos for correction of dystrophin in mouse models of duchenne muscular dystrophy
by: Betts, C, et al.
Published: (2014)

Targeted Exon Skipping to Correct Exon Duplications in the Dystrophin Gene
by: Kane L Greer, et al.
Published: (2014-01-01)

Targeted skipping of human dystrophin exons in transgenic mouse model systemically for antisense drug development.
by: Bo Wu, et al.
Published: (2011-01-01)

Dystrophin Cytochemistry in Mdx Mouse Muscles Injected with Labeled Normal Myoblasts
by: Ming Chen, et al.
Published: (1992-01-01)

Targeted Exon Skipping to Address “Leaky” Mutations in the Dystrophin Gene
by: Sue Fletcher, et al.
Published: (2012-01-01)

In vivo restoration of dystrophin expression in mdx mice using intra-muscular and intra-arterial injections of hydrogel microsphere carriers of exon skipping antisense oligonucleotides
by: Shani Attias Cohen, et al.
Published: (2022-09-01)

Cmah-dystrophin deficient mdx mice display an accelerated cardiac phenotype that is improved following peptide-PMO exon skipping treatment
by: Betts, C, et al.
Published: (2018)

To dystrophin and beyond: an interview with Louis Kunkel
by: Louis M. Kunkel, et al.
Published: (2020-02-01)

Pip5 transduction peptides direct high efficiency oligonucleotide-mediated dystrophin exon skipping in heart and phenotypic correction in mdx mice.
by: Yin, H, et al.
Published: (2011)

Pip5 transduction peptides direct high efficiency oligonucleotide-mediated dystrophin exon skipping in heart and phenotypic correction in mdx mice
by: Yin, H, et al.
Published: (2011)

Expression and function of four AAV-based constructs for dystrophin restoration in the mdx mouse model of Duchenne muscular dystrophy
by: Rachael A. Potter, et al.
Published: (2023-09-01)

The effects of low levels of dystrophin on mouse muscle function and pathology.
by: Maaike van Putten, et al.
Published: (2012-01-01)

Extensive and prolonged restoration of dystrophin expression with vivo-morpholino-mediated multiple exon skipping in dystrophic dogs.
by: Yokota, T, et al.
Published: (2012)

Metabolic remodeling agents show beneficial effects in the dystrophin<it>-</it>deficient <it>mdx</it> mouse model
by: Jahnke Vanessa E, et al.
Published: (2012-08-01)

Non-uniform dystrophin re-expression after CRISPR-mediated exon excision in the dystrophin/utrophin double-knockout mouse model of DMD
by: Hanson, B, et al.
Published: (2022)

Non-uniform dystrophin re-expression after CRISPR-mediated exon excision in the dystrophin/utrophin double-knockout mouse model of DMD
by: Britt Hanson, et al.
Published: (2022-12-01)

Multiomic characterization of disease progression in mice lacking dystrophin.
by: Mirko Signorelli, et al.
Published: (2023-01-01)

Histone deacetylase inhibitors improve antisense-mediated exon-skipping efficacy in mdx mice
by: Flavien Bizot, et al.
Published: (2022-12-01)

Cell-mediated exon skipping normalizes dystrophin expression and muscle function in a new mouse model of Duchenne Muscular Dystrophy
by: Francesco Galli, et al.
Published: (2024-03-01)

Recombinase-mediated reprogramming and dystrophin gene addition in mdx mouse induced pluripotent stem cells.
by: Chunli Zhao, et al.
Published: (2014-01-01)

Deletion of Dystrophin In-Frame Exon 5 Leads to a Severe Phenotype: Guidance for Exon Skipping Strategies.
by: Zhi Yon Charles Toh, et al.
Published: (2016-01-01)

Influence of full-length dystrophin on brain volumes in mouse models of Duchenne muscular dystrophy.
by: Bauke Kogelman, et al.
Published: (2018-01-01)

Networking to Optimize <i>Dmd</i> exon 53 Skipping in the Brain of <i>mdx52</i> Mouse Model
by: Mathilde Doisy, et al.
Published: (2023-12-01)

Peptide Nucleic Acid Promotes Systemic Dystrophin Expression and Functional Rescue in Dystrophin-deficient mdx Mice
by: Xianjun Gao, et al.
Published: (2015-01-01)

Peptide Nucleic Acid Promotes Systemic Dystrophin Expression and Functional Rescue in Dystrophin-Deficient mdx Mice
by: Xianjun Gao, et al.
Published: (2020-12-01)

Testing of SHIRPA, a mouse phenotypic assessment protocol, on Dmd(mdx) and Dmd(mdx3cv) dystrophin-deficient mice.
by: Rafael, J, et al.
Published: (2000)

Increased neointimal thickening in dystrophin-deficient mdx mice.
by: Uwe Rauch, et al.
Published: (2012-01-01)

Persistence of exon 2 skipping and dystrophin expression at 18 months after U7snRNA-mediated therapy in the Dup2 mouse model
by: Liubov V. Gushchina, et al.
Published: (2023-12-01)

Optimization of peptide nucleic acid antisense oligonucleotides for local and systemic dystrophin splice correction in the mdx mouse.
by: Yin, H, et al.
Published: (2010)

Context dependent effects of chimeric peptide morpholino conjugates contribute to dystrophin exon-skipping efficiency
by: Yin, HF, et al.
Published: (2016)

Rescu of severely affected dystrophin/utrophin deficient mice by morpholino-oligomer mediated exon skipping
by: Goyenvalle, A, et al.
Published: (2010)